 |
Oviedo, Teatro de Campoamor |
|
Oviedo, Teatro de Campoamor |
| HEAD OF THE UNIT | Prof Jorge B. Cannata Andia |
| CLINICAL STAFF | Dr Carlos Gómez Alonso, Dr Minerva Rodriguez Garcia |
| RESEARCH STAFF | Dr José Luis Fernandez Martin, Dr Manuel Naves Diaz |
 |
|
| CONTACT
INFORMATION |
|
| metoseo@hca.es | |
| PHONE: | +34-985-106137 |
| FAX: | +34-985-106142 |
| FULL POSTAL ADDRESS | Hospital Universitario Central de Asturias, C/Julian Clavería S/N, 33006 Oviedo, Spain |
RESEARCH INTERESTS
Clinical projects
| Aluminium toxicity |
| • Evaluation of bone mineralization in uraemia. Response to different treatments and effect of desferrioxamine in patients with normal renal function and renal insufficiency. FIS 87/1476 (1987-1989). Main Researcher: Prof Jorge B. Cannata Andia |
| • Treatment of aluminium intoxication: analysis of new therapeutic ways and mechanisms of action. FISss 91/0329; (1991-1993). Main Researcher: Prof Jorge B. Cannata Andia |
| Osteoporosis |
| • Bone mass in the Spanish Population. Project CREO-DGF (1989-1992). Main Researcher: Prof Jorge B. Cannata Andia |
| • Prevalence, risk factors and impact of vertebral osteoporosis in Europe: Role of the biological markers and histology in the assessment of the therapeutic response in osteoporotic fractures. FISss 91/E0747 (1991-1993). Main Researcher: Prof Jorge B. Cannata Andia |
| • Bone mass and fractures: Evolutive study. Proyecto multicéntrico PPR 1993-1995. Main Researcher: Prof Jorge B. Cannata Andia |
| • Spanish vertebral osteoporosis study. Analysis of risk factors. FIS 94/1901-E (1994-1996). Main Researcher: Prof Jorge B. Cannata Andia |
Renal Osteodystrophy |
• Evolutive control of renal osteodistrophy in Iberoamerica (CORES). Main Researcher: Prof Jorge B. Cannata Andia |
| • Current management Of Secondary Hyperparathyroidism: Multicentre Observational Study (COSMOS) (Amgen 2005-2008). Main Researcher: Prof Jorge B. Cannata Andia |
• European vertebral osteoporosis study (EVOS). European community. BIOMED I (1991-1993). Investigador responsable: Dr. JB Cannata |
• European prospective osteoporosis study.(EPOS). European community. BIOMED 93-95 BMHI-CT 092-0182. (1993 -1997). Investigador Responsable. Dr. JB Cannata |
Basic projects
| Aluminium toxicity |
| • Contribution of the Analytical chemistry to trace elements analysis of importance in Medicine and Biology. CAICYT N - PR-83-2837-CO2-O2 1984-1987), Ministry of Education and Science). Main Researchers: Prof. A Sanz Medel and Prof Jorge B. Cannata Andia. |
| • Effect of aluminium in cardiac performance. FICYT 1987/1989. Main Researcher: Prof Jorge B. Cannata Andia |
| • New trends in analytical toxicology. Its contribution to renal diseases. CICYT PM 88/0183 (1.989-1.991) Main Researchers: Prof Jorge B. Cannata Andia and Prof. Sanz Medel. |
| • New chelating drugs the treatment of aluminium intoxication. FICYT (1989-1991). Main Researcher: Prof Jorge B. Cannata Andia |
| • Kinetic and experimental studies with chelating agents. IRSIN-FRIAT. 1996-1997. Main Researcher: Prof Jorge B. Cannata Andia |
| • Molecular mechanism of parathyroid hormone inhibition by aluminium in parathyroid glands cultured “in vitro”. FIS 01/0294 - 2001-2003. Main Researcher: José Luis Fernández Martín |
Vascular calcifications |
| • Search and identification of new proteins involved in vascular calcifications in chronic kidney diseases. Effect of different factors on VSM cells (FIS 04/1476). Main Researcher: José Luis Fernández Martín |
| Renal Osteodystrophy |
| • Effect of estradiol and calcitriol on the progression of renal osteodystrophy in an animal model with renal insufficiency and ovaric insufficiency. FIS 02/ 0613, 2003-2005. Main Researcher: Manuel L Naves Díaz |
| • Regulation of the parathyroid function mediated by receptors in parathyroid glands cultured “in vitro”. FIS 2003-2005 Main Researcher: Prof Jorge B. Cannata Andia |
| • Análysis of influence of calcium receptor gene polymorphisms in the response to AMG073 (cinacalcet hydrochloride) Main Researcher: Prof Jorge B. Cannata Andia. |
• Expresión de genes y proteínas implicados en el desarrollo del hiperparatiroidismo secundario y de las calcificaciones vasculares en el insuficiencia renal crónico. FICYT IB05-060. 2005-2007. Main Researcher : Prof. Jorge B. Cannata Andía. |
Basic-Clinical projects
| Aluminium toxicity |
| • Aluminium gastrointestinal absorption. Clinical and experimental study. FIS 87/1475 (1987-1988). Main Researcher: Prof Jorge B. Cannata Andia |
| • Effect of aluminium in bone metabolism: Clinical and molecular approach. Sociedad Española de Nefrología. 2000-2002. Main Researcher: Prof Jorge B. Cannata Andia |
| Renal Osteodystrophy |
• Prevention, mechanism of toxicity and new diagnostic and therapeutic approaches in renal osteodystrophy. IRSIN-FRIAT. 1995. Main Researcher: Prof Jorge B. Cannata Andia |
| • Epidemiological and experimental approach to high and low-bone turnover. IRSIN-FRIAT 1998-2000. Main Researcher: Prof Jorge B. Cannata Andia |
| • Hormonal replacement therapy in chronic renal failure: Clinical and experimental study. FIS 98/787.1998-2000. Main Researcher: Prof Jorge B. Cannata Andia |
| • Clinical, epidemiological and experimental study on different aspects of renal osteodystrophy. IRSIN-FRIAT 1999-2002. Main Researcher: Prof Jorge B. Cannata Andia |
| • Effect of vitamin D receptor polymorphisms on parathyroid gland function. FIS 00/0008-02. 2000-2002. Main Researcher: Dr Manuel Naves |
| • Search, identification and analysis of the genes implicated in the development of monoclonality and autonomy in the secondary hiperparathyroidism. FIS 01/3124, 2001-2003. Main Researcher: Iñigo Santamaría Ruiz de Azúa |
| • Use of DNA arrays to study the progression of secondary hiperparathyroidism. FICYT 2002-2004. |
| Main Researcher: Iñigo Santamaría Ruiz de Azúa |
Peer Reviewed Publications in International Journals (only English) 2000-2006
Publications list
2006
| Vitamin D supplementation:what is right? Alvarez-Hernandez D, Gómez Alonso C, Cannata JB. Clinical Cases in Mineral and Bone Metabolism. 3:71-75, 2006 |
| A critical role for enhance-TGF and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Cozzolino M, Lu Y, Sato T, Yang J, González-Suárez I, Brancaccio D, Slatopolsky E, Dusso A. Am J Physiology, 2006 (in press) |
| Requirements for DXA for the management of osteoporosis in Europe. Kanis J, Johnell O, IOF CSA. Osteoporos Int, 2006 (in press) |
| Vascular Calcifications: Parhogenesis, Management and impact on clinical outcomes. Cannata JB, Rodríguez García M, Carrillo-López N, Fernández Martín JL, Naves Díaz M. JASN, 2006 (in press) |
| Supplementation of Vitamin D and calcium: Advantages and Risks. Díaz López JB, Cannata JB. Nephrol Dial Transplant, 2006 (in press) |
| The relationship between osteoporosis and vascular calcifications in general and dialysis populations. Naves Díaz M, Rodriguez-Garcia M, Cannata JB. Touch Briefings, 2006(in press) |
2005
| Long-term response of cultured rat parathyroid glands to calcium and calcitriol: The effect of cryopreservation. Alvarez-Hernandez D, González-Suárez I, Naves M, Carrillo-López N, Fernández-Coto M, Fernández-Martín JL, Cannata JB. J Nephrol 18:141-147, 2005 |
| Low BMD in less predictive than reported falls for future limb fractures in women across Europe: results from European Prospctive Osteoporosis Study. Kaptoge S, Benevolenskaja L, Bhalla AK, Cannata JB, Boonen S, Falch JA, Felsemberg D, Finn JD, Hoszowski K, Lorenc R, Miazgowski T, Jajic I, Lyritis G, Masaryk P, Naves Díaz M, Poor G, Reid D, Scheidt Nave C, Stepan J, Todd C, Weber K, Woolf A, Roy DK, Lunt M, Pye SR, O´Neill TW, Silman A, Reeve J. Bone 36:387-398, 2005 |
| Prevalence of osteoporosis in men and determinants of changes in bone mass in non-selected Spanish population. Naves Díaz M, Díaz López JB, Gómez Alonso C, Rodríguez Rebollar A, Serrano Arias M, Cannata JB. Osteoporos Int 16:603-609, 2005 |
| Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with Osteoporosis: Treatmen of Peripheral Osteoporosis (TROPOS) Study. Reginster JY, Seeman E, Vernejoul De MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Díaz Curiel M, Sawicki AG, S., Sorensen OH, Felsenberg D, Meunier PJ. J Clin Endocrinol Metab 90:2816-2822, 2005 |
| Progression of secondary hyperparathyroidism involves deregulation of genes relates to DNA and RNA stability. Santamaría I, Alvarez-Hernandez D, Jofré R, Polo JR, Menárguez J, Cannata JB. Kidney Int. 67:2267-2279, 2005 |
| The management of postmenopausal osteoporosis: A position paper of the world health origination collaborating center on public health aspects of rheumatic. Delmas P, Khaltaev N, Arriagada M, Brandi ML, Cannata JB, Lau EMC, Lederman R, Lorenc R, Minne J, Morales-Torres J, Morii H, Sambrook T, Torralba J, Zanchetta JR, Reginster JY. JMNI 5:105-109, 2005 |
| Aluminium post-transcriptional regulation of parathyroid hormone synthesis: A role for the calcium-sensing receptor. González-Suárez I, Alvarez-Hernandez D, Carrillo-López N, Naves Díaz M, Fernández Martín JL, Cannata JB. Kidney Int 68:2484-2496, 2005 |
| Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50. Naves Díaz M, Díaz López JB, Gómez Alonso C, Rodríguez-Rebollar A, Cannata JB. Osteoporos Int, 16 :2013-2017, 2005 |
| Bone metabolism, vascular cacifications and mortality: Associations beyond mere coincidence. Rodríguez García M, Naves Díaz M, Cannata JB. J Nephrol 18: 458-463, 2005 |
| Genetics and molecular disorders in severe secondary hiperparathyroidism: Lessons from RNA and microarrays studies. Santamaría I, Alvarez-Hernandez D, Cannata JB. J Nephrol 18:469-473, 2005 |
| Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study. Siris ES, Harris ST, Eastell R, Zanchetta JR, Goemaere S, Díez-Pérez A, Stock JL, Song J, Qu Y, Kulkarni PM, Siddhanti SR, Wong M, Cummings SR. J Bone Miner Res 20:1414-1524, 2005. |
2004
| Health-related quality of life and radiographic vertebral fracture. Cockerill W, Lunt M, Silman A, Cooper C, Lips P, Bhalla AK, Cannata JB, Eastell R, Felsenberg D, Gennari C, Johnell O, Kanis J, Kiss C, Masaryk P, Naves Díaz M, Poor G, Raspe A, Reid D, Reeve J, Stepan J, Todd C, Woolf A, O`Neill TW. Osteoporos Int 15:113-119, 2004 |
| Osteoporosis in chronic kidney disease. Cunningham J, Sprague SM, Cannata JB, Coco M, Cohen-Solal M, Fitzpatrick L, Goltzmann D, Lafage-Proust MH, Leonard M, Ott S, Rodríguez M, Stehman-Breen C, Stern P, Weisinger J. Am J Kidney Dis 43:566-571, 2004 |
| The Effects of Strontium ranelate reduces the risk of vertebral fracture in women with postmenopausal osteoporosis. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski J, Spector T, Cannata JB, Balogh A, Lemmel EM, Rizzoli R, Pors-Nielsen S, Reginster JY. New Engl J Med 350:459-468, 2004 |
| Cloning of a new familial t (3;8) translocation associated with conventional renal cell carcinoma reveals a 5 Kb microdeletion and no gene involved in the rearrangement. Rodríguez-Perales S, Meléndez B, M Gribble S, Valle L, Carter NP, Santamaria I, Conde L, Urioste M, Benitez J, Cigudosa JC. Human Molecular Genetics 13:983-990, 2004 |
| Is bone mineral density a useful parameter for monitor the treatment of osteoporosis in post-menopausal women? Cannata JB, Ringe JD, Kendler D, Lorenc RS, El-Badawy SA, Lau EMC, Meng XW, Nielsen SP. Medico Graphia New Steps in Osteoporosis 26:271-281, 2004 |
| Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. O' Neill T, Cockerill W, Matthis C, Raspe A, Lunt M, Cooper C, Banzer D, Cannata JB, Naves Díaz M, Felsch B, Felsenberg D, Janott J, Johnell O, Kanis J, Kragl G, Lopes Vaz A, Lyritis G, Masaryk P, Poor G, Reid D, Reisinger W, Scheidt Nave C, Stepan J, Todd C, Woolf A, Reeve J, Silman A. Osteoporos Int 15:760-765, 2004 |
| "When Should the Doctor Order a Spine X-Ray? Identifying Vertebral Fractures for Osteoporosis Care: Results From the European Prospective Osteoporosis Study (EPOS). Kaptoge, S., G. Armbrecht, et al. " J Bone Miner Res 19: 1982-1993,2004 |
2003
| Chromosomal aberrations, the consequence of refractory hyperparathyroidism: Its relationship with biochemical parameters. Afonso S, Santamaria I, Guinsburg ME, Otero Gómez A, García Miranda JL, Jofré R, Menárguez J, Cannata-Andia J, Cigudosa JC. Kidney Int 63 (suppl. 85):S32-S38, 2003 |
| Influence of polymorphisms in VDR and COLIA1 genes on the risk of osteoporotic fractures in aged men. Alvarez-Hernandez D, Naves M, Diaz-Lopez JB, Gomez C, Santamaria I, Cannata-Andia JB. Kidney Int 63 (suppl.85):S14-S18, 2003 |
| Advances in Renal Osteodystrophy- IV International Symposium. Cannata-Andia JB, Fernandez-Martin JL, Santamaria I. Kidney Int 63 (suppl. 85):S1, 2003 |
| Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levels. Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT, Cannata-Andia JB. Kidney Int Suppl 63 (suppl. 85):S44-S48, 2003 |
| Effect of aluminium on calcium-sensing receptor expression, proliferation, and apoptosis of parathyroid glands from rats with chronic renal failure. Gonzalez-Suarez I, Naves M, Diaz-Corte C, Fernandez-Martin JL, Menendez-Rodriguez P, Cannata-Andia JB. Kidney Int 63 (suppl. 85):S39-S43, 2003 |
| Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised placebo-controlled study. Hosking D, Adami S, Felsenberg D, Cannata JB, Välimaki M, Benhamou L, Reginster JY, Yacik C, Rybak-Feglin A, Petruschke RA, Zaru L, Santora AC. Current medical research and opinion. 19(5):P1-P11, 2003 |
| Characteristics of a Prevalent Vertebral Deformity Predict Subsequent Vertebral Fracture: Results from the European Prospective Osteoporosis Study (EPOS). Lunt M, O' Neill T, Felsenberg D, Reeve J, Kanis J, Cooper C, Silman A. Bone 33:505-513, 2003 |
| Effect of VDR gene polymorphisms on osteocalcin secretion in calcitriol-stimulated human osteoblasts. Naves M, Alvarez-Hernandez D, Fernandez-Martin JL, Paz-Jimenez J, Garcia-Prado P, Fernandez-Coto T, Santamaria I, Cannata-Andia J. Kidney Int 63 (suppl. 85):S23-S27, 2003 |
| The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a sphanish population. Naves Díaz M, Díaz López JB, Gómez Alonso C, Rodríguez Rebollar A, Rodríguez García M, Cannata JB. Osteoporos Int 14:520-524, 2003 |
| Determinants of the size of incident vertebral deformities in european men and women in the 6th-9th decades of age: The European prospective osteoporosis Study (EPOS). O' Neill T, Lunt M, Silman A, Felsenberg D, Benevolenskaja L, Bhalla AK, Cannata JB, Cooper C, Crabtree N, Dequeker J, Hoszowski K, Jajic I, Kanis J, Kragl U, López Vaz A, Lorenc R, Lyritis G, Masaryk P, Miazgowski T, Parisi G, Pols H, Poor G, Reid D, Scheidt Nave C, Stepan J, Todd C, Weber K, Woolf A, Reeve J. JBMR 18(9):1664-1673, 2003 |
| Advantages of adjusting the initial dose of intravenous calcitriol according to PTH levels. Rodriguez-Garcia M, Fernandez-Martin JL, De Castaneda JR, Hervas-Sanchez J, Cannata-Andia JB. Kidney Int 63 (suppl. 85):S79-S82, 2003 |
| Hormonal replacement therapy in an animal model with chronic renal failure and ovariectomy: Biochemical and densitometric study. Rodriguez-Rodriguez A, Naves M, Rodriguez-Rebollar A, Gomez C, Braga S, Cannata-Andia JB. Kidney Int 63 (suppl. 85):S57-S61, 2003 |
| Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Roy DK, O' Neill T, Finn JD, Lunt M, Silman A, Felsenberg D, Armbrecht G, Banzer D, Benevolenskaja L, Bhalla AK, Bruges J, Armas JB, Cannata JB, Cooper C, Dequeker J, Díaz MN, Eastell R, Yershova OB, Felsch B, Gowin W, Havelka S, Hoszowski K, Ismail AA, Jajic I, Janott J, Johnell O, Kanis J, Kragl G, López Vaz A, Lorenc R, Lyritis G, Masaryk P, Matthis C, Miazgowski T, Gennari C, Pols H, Poor G, Raspe HH, Reid D, Reisinger W, Scheidt Nave C, Stepan J, Todd C, Weber K, Woolf A, Reeve J. Osteoporos Int 14:19-26, 2003 |
| Risk factors for Colles' fracture in men and women: results from the European Prospective Osteoporosis Study. Silman A. Osteoporos Int 14:213-218, 2003 |
| A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms. Álvarez Hernández D, Santamaría I, Rodríguez García M, Iglesias P, Delgado-Lillo R, Cannata JB. Journal of Molecular Endocrinology 31:255-262, 2003 |
| Response of parathyroid glands to calcitriol in culture. Is this response mediated by the genetic polymorphisms in vitamin D receptor? Álvarez-Hernández D, Naves M, Santamaría I, Menárguez J, Torregrosa V, Cannata JB. Kidney Int 63 (suppl. 85):S19-S22, 2003 |
2002
| Hyperphosphataemia as cardiovascular risk factor. How to manage the problem. Cannata Andia JB, Rodríguez García M. Nephrol Dial Transplant 17 (Suppl 11):16-19, 2002 |
| Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure. Cannata-Andia JB, Gómez Alonso C. Nephrol Dial Transplant 17:1875-1878, 2002 |
| The clinical impact of aluminium overload in real failure. Cannata-Andía JB, Fernández-Martín JL. Nephrol Dial Transplant 17 (Suppl 2):9-12, 2002 |
| The Relationship Between Bone Density and Incident Vertebral Fracture in Men and Women. EPOS Study Group, O' Neill T, Lunt M, Silman A, Felsenberg D, Benevolenskaja L, Bhalla AK, Cannata JB, Cooper C, Crabtree N, Dequeker J, Hoszowski K, Jajic I, Kanis J, Kragl U, Lopes Vaz A, Lorenc R, Lyritis G, Masaryk P, Miazgowski T, Parisi G. J Bone Miner Res 17 (12):2214-2221, 2002 |
| Incidence of vertebral fracture in Europe: results from the european prospective osteoporosis study (EPOS). European Prospective Osteoporosis Study (EPOS) Group. J Bone Miner Res 14:716-724, 2002 |
| Incidence of Limb Fracture across Europe: Results from the European Prospective Osteoporosis Study (EPOS). Ismail AA, Pye SR, Cockerill W, Lunt M, Silman A, Reeve J, Banzer D, Benevolenskaja L, Bhalla AK, Bruges J, Cannata JB, Cooper C, Delmas P, Dequeker J, Dilsen G, Falch J, Felsch B, Felsenberg D, Finn JD, Gennari C, Hoszowski K, Jajic I, Janott J, Johnell O, Kanis J, Kragl U, López Vaz A, Lorenc R, Lyritis G, Marchand F, Masaryk P, Matthis C, Miazgowski T, Naves Díaz M, Pols H, Poor G, Rapado A, Raspe A, Reid D, Reisinger W, Sheidt-Nave C, Stepan J, Todd C, Weber K, Woolf A, O' Neill T. Osteoporos Int 13:565-571, 2002 |
| Nutritional status in dialysis patients: a European consensus. Locatelli F, Fouque D, Heimburger O, Drüeke T, Cannata-Andía JB, Hörl WH, Ritz E. Nephrol Dial Transplant 17:563-572, 2002 |
| Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Locatelli F, Cannata JB, Drüeke T, Hörl WH, Fouque D, Heimburger O, Ritz E. Nephrol Dial Transplant 17:723-731, 2002 |
| Defining Incident Vertebral Deformities in Population Studies: A Comparison of Morphometric Criteria. Lunt M, Ismail AA, Felsenberg D, Cooper C, Kanis J, Reeve J, Silman A, O' Neill T, Group Es. Osteoporos Int 13:809-815, 2002 |
| Falls Explain Between-Center Differences in the Incidence of Limb Fracture across Europe. Roy DK, Pye SR, Lunt M, O'Neill T, Todd C, Raspe A, Reeve J, Silman A. Bone 31(6):712-717, 2002 |
| Quantitative ultrasound calcaneus measurements: normative data and precision in the spanish population. Sosa M, Saavedra P, Muñoz-Torres M, Alegre J, Gómez C, González-Macías J, Guañabens N, Hawkins F, Lozano C, Martínez M, Mosquera J, Pérez-Cano R, Quesada M, Salas E, The GIUMO Study Group. Osteoporos Int 13:487-492, 2002 |
2001
| Measuring quality of life in women with vertebral fractures due to osteoporosis: A comparison of the OQLQ and QUALEFFO. (The Spanish GRECO Study Group). Badía X, Díez-Pérez A, Alvarez-Sanz C, Díaz López JB, Díaz-Curiel M, Guillén F, González-Macías J. Quality of Life Research 10:307-317, 2001 |
| Vertebral involvement in hyperphosphatemic tumoral calcinosis. Blay P, Fernández-Martinez JM, Díaz López JB. Bone 28:316-318, 2001 |
| Reconsidering the importance of long-term low-level aluminum exposure in renal failure patients. Cannata-Andía JB. Semin Dial 14:5-7, 2001 |
| Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, Farrerons J, Karasik A, Mellstrom D, Ng KW, Stepan JJ, Powles TJ, Morrow M, Costa A, Silfen SL, Walls EL, Schmitt H, Muchmore DB, Jordan VC, Group MOoRE. Breast Cancer Res Treat 65:125-134, 2001 |
| Effect of aluminium load on parathyroid hormone synthesis. Díaz-Corte C, Fernández-Martín JL, Barreto S, Gómez C, Fernández-Coto T, Braga S, Cannata JB. Nephrol Dial Transplant 16:742-745, 2001 |
| Bone aluminum uptake in uremic rats receiving intraperitoneal iron. Fernández Martín JL, Fernandez-Soto I, Acuña G, Cannata-Andia JB. Biol Trace Elem Res 84:129-137, 2001 |
| Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Ismail AA, Cockerill W, Cooper C, Finn JD, Abendroth K, Parisi G, Banzer D, Benevolenskaya LI, Bhalla AK, Armas JB, Cannata JB, Delmas PD, Dequeker J, Dilsen G, Eastell R, Ershova O, Falch JA, Felsch B, Havelka S, Hoszowski K, Jajic I, Kragl U, Johnell O, López Vaz A, Lorenc R, Yriti GL, Marchand F, Masary P, Matthis C, Miazgowski T, Pols HA, Poor G, Rapado A, Raspe HH, Reid DM, Reisinger W, Janott J, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, Ambrecht G, Gowin W, Felsenberg D, Lunt M, Kanis JA, Reeve J, Silman AJ, O'Neill TW. Osteoporosis Int 12:85-90, 2001 |
| The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Lunt M, Masaryk P, Scheidt-Nave C, Nijs J, Poor G, Pols H, Falch JA, Hammermeister G, Reid DM, Benevolenskaya L, Weber K, Cannata J, O'Neill TW, Felsenberg D, Silman AJ, Reeve J. Osteoporosis Int 12:688-698, 2001 |
| Exploratory investigations on the potential of radiofrecuency glow discharge-optical emission spectrometry for the direct elemental analysis of bone. Martínez R, Pérez C, Bordel N, Pereiro R, Fernández-Martín JL, Cannata JB, Sanz Medel A. J Anal Atom Spectrom 16:240-255, 2001 |
| Reference values for trace and ultratrace elements in human serum determined by double-focusing ICP-MS. Muñiz CS, Fernández-Martín JL, Marchante-Gayon JM, García Alonso JI, Cannata-Andía JB, Sanz-Medel A. Biol Trace Elem Res 82:259-272, 2001 |
2000
| Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Alonso CG, Curiel MD, Carranza FH, Cano RP, Pérez AD, Osteoporosis MPfRi. Osteoporos Int 11:714-720, 2000 |
| Adynamic Bone and Chronic Renal Failulre: And Overview. Cannata Andía JB. Am J Med Sci 320:81-84, 2000 |
| Pathogenesis, prevention and management of low-bone turnover. Cannata-Andía JB. Nephrol Dial Transplant 15 (Suppl 5):15-17, 2000 |
| Use of ultrafiltration and chromatography to assess aluminum speciation in serum after deferoxamine administration. Canteros-Picotto A, Fernández-Martín JL, Cannata-Andía JB. Am J Kidney Dis 36:969-975, 2000 |
| Does location of vertebral deformity within the spine influence back pain and disability? European Vertebral Osteoporosis Study (EVOS) Group. Cockerill W, Ismail AA, Cooper C, Matthis C, Raspe H, Silman AJ, O'Neill TW, Group EVOS. Ann Rheum Dis 59:368-371, 2000 |
| Management of secondary hyperparathyroidism: the gap between diagnosis and treatment. The Renal Osteodystrophy Multicenter Enquiry. Díaz-Corte C, Cannata-Andía JB. Am J Med Sci 320:107-111, 2000 |
| Aluminum exposure in chronic renal failure in Iberoamerica at the end of the 1990s: overview and perspectives. Fernández-Martín JL, Canteros A, Alles A, Massari P, Cannata-Andía J. Am J Med Sci 320:96-99, 2000 |
| Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas. Hajeer AH, Lear JT, Ollier WER, Naves M, Worthington J, Bell DA, Smith AG, Bowers WP, Jones PW, Strange RC, Fryer AA. Brithish Journal of Dermatology 142:441-445, 2000 |
| Risk factors for vertebral deformities in men: relationship to number of vertebral deformities. Ismail AA, O'Neill TW, Cooper C, Silman AJ, Group EVOS. J Bone Miner Res 15:278-283, 2000 |
| Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Ismail AA, O'Neill TW, Cockerill W, Finn JD, Cannata JB, Hoszowski K, Johnell O, Matthis C, Raspe H, Raspe A, Reeve J, Silman AJ. Osteoporos Int 11:248-254, 2000 |
| Different patterns of renal osteodystrophy in Iberoamerica. Jorgetti V, López BD, Caorsi H, Ferreira A, Palma A, Menéndez P, Douthat W, Olaizola I, Ribeiro S, Jarava C, Moreira E, Cannata J. Am J Med Sci 320:76-80, 2000 |
| Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Rebollo P, Ortega F, Baltar JM, Badía X, Alvarez-Ude F, Díaz-Corte C, Naves M, Navascues RA, Ureña A, Alvarez-Grande J. Clin Transplant 14:199-207, 2000 |
European
Fellows programme
Specify
if the Unit accepts fellows from European countries for:
Short (1-2 month) well focused training programs either clinically or
laboratory oriented.
Long (at least 1 year) research fellowships: We can accept both
long and short fellowship.
Specify corresponding availability of grants: No.
Specify if the Unit may provide help for accommodation: Yes (if
space is available).
Prerequisites for Fellowship
Language: English and/or Spanish.
Work/Research experience: Preferable.
Other prerequisites: to work in the area of bone metabolism.